Literature DB >> 16685001

Transbronchial biopsy in usual interstitial pneumonia.

Ema A Berbescu1, Anna-Luise A Katzenstein, Jennifer L Snow, David A Zisman.   

Abstract

BACKGROUND: Usual interstitial pneumonia (UIP) is a slowly progressive, usually fatal form of idiopathic interstitial pneumonia for which there is no effective treatment. Transbronchial biopsy (TBB) has been utilized only to exclude other diseases such as sarcoidosis, lymphangitic carcinoma, and infection, for example, but TBB is generally considered to have little role in confirming UIP.
OBJECTIVE: To determine whether diagnostic changes of UIP can be appreciated on TBB specimens.
DESIGN: Retrospective analysis of TBB specimens from patients with proven UIP.
SETTING: Two study sites in the United States. PARTICIPANTS: Twenty-one patients with UIP confirmed by surgical lung biopsy and/or lung explant, and 1 patient with UIP confirmed by clinical and radiographic findings along with follow-up information. MEASUREMENTS AND
RESULTS: Adequate tissue for diagnosis was available in 18 cases; in 7 cases (32% overall), there were varying combinations of interstitial fibrosis in a patchwork pattern along with fibroblast foci and/or honeycomb change. These features were considered diagnostic of UIP. Interstitial fibrosis along with fibroblast foci or honeycomb change were seen in two other cases, but the fibrosis lacked a patchwork pattern, and these features were considered consistent with UIP. Nonspecific interstitial fibrosis alone was found in nine cases.
CONCLUSIONS: In summary, characteristic histologic features of UIP can be identified on TBB specimens more often than previously appreciated. TBB may be more useful in confirming UIP than previously recognized.

Entities:  

Mesh:

Year:  2006        PMID: 16685001      PMCID: PMC2094131          DOI: 10.1378/chest.129.5.1126

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Usual interstitial pneumonia: histologic study of biopsy and explant specimens.

Authors:  Anna-Luise A Katzenstein; David A Zisman; Leslie A Litzky; Binh T Nguyen; Robert M Kotloff
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

3.  Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.

Authors:  Gary W Hunninghake; David A Lynch; Jeffrey R Galvin; Barry H Gross; Nestor Müller; David A Schwartz; Talmadge E King; Joseph P Lynch; Richard Hegele; James Waldron; Thomas V Colby; James C Hogg
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

6.  High short-term mortality following lung biopsy for usual interstitial pneumonia.

Authors:  J P Utz; J H Ryu; W W Douglas; T E Hartman; H D Tazelaar; J L Myers; M S Allen; D R Schroeder
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

7.  Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia.

Authors:  Leena Tiitto; Ulla Heiskanen; Risto Bloigu; Paavo Pääkkö; Vuokko Kinnula; Riitta Kaarteenaho-Wiik
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

  7 in total
  28 in total

1.  Integration and Evaluation of Clinical Decision Support Systems for Diagnosis Idopathics Pulmonary Fibrosis (IPF).

Authors:  Yunhee Lee; Youngmoon Chae; Sungwan Jeon
Journal:  Healthc Inform Res       Date:  2010-12-31

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 3.  Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges.

Authors:  Robert J Lentz; A Christine Argento; Thomas V Colby; Otis B Rickman; Fabien Maldonado
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy.

Authors:  S Piciucchi; M Romagnoli; M Chilosi; C Bigliazzi; A Dubini; B Beomonte Zobel; G Gavelli; A Carloni; V Poletti
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

5.  Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

Authors:  Jonathan A Kropski; Jason M Pritchett; Donald F Zoz; Peter F Crossno; Cheryl Markin; Errine T Garnett; Amber L Degryse; Daphne B Mitchell; Vasiliy V Polosukhin; Otis B Rickman; Leena Choi; Dong-Sheng Cheng; Melinda E McConaha; Brittany R Jones; Linda A Gleaves; Frank B McMahon; John A Worrell; Joseph F Solus; Lorraine B Ware; Jae Woo Lee; Pierre P Massion; Rinat Zaynagetdinov; Eric S White; Jonathan D Kurtis; Joyce E Johnson; Steve D Groshong; Lisa H Lancaster; Lisa R Young; Mark P Steele; John A Phillips Iii; Joy D Cogan; James E Loyd; William E Lawson; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

6.  The diagnosis efficacy and safety of video-assisted thoracoscopy surgery (VATS) in undefined interstitial lung diseases: a retrospective study.

Authors:  Qun Luo; Qian Han; Xiaobo Chen; Jiaxing Xie; Lulu Wu; Rongchang Chen
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

7.  Utility of Flexible Bronchoscopic Cryobiopsy for Diagnosis of Diffuse Parenchymal Lung Diseases.

Authors:  Robert J Lentz; Trevor M Taylor; Jonathan A Kropski; Kim L Sandler; Joyce E Johnson; Timothy S Blackwell; Fabien Maldonado; Otis B Rickman
Journal:  J Bronchology Interv Pulmonol       Date:  2018-04

Review 8.  Diagnosis of idiopathic pulmonary fibrosis: Current issues.

Authors:  Rajendra Prasad; Nikhil Gupta; Abhijeet Singh; Pawan Gupta
Journal:  Intractable Rare Dis Res       Date:  2015-05

Review 9.  Interstitial lung disease: the diagnostic role of bronchoscopy.

Authors:  Jad Kebbe; Tony Abdo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 10.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.